430 related articles for article (PubMed ID: 32503412)
1. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
Jadamba E; Shin M
Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
[TBL] [Abstract][Full Text] [Related]
3. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.
Jia Z; Liu Y; Guan N; Bo X; Luo Z; Barnes MR
BMC Genomics; 2016 May; 17():414. PubMed ID: 27234029
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
5. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
Karatzas E; Kolios G; Spyrou GM
Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
7. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
[TBL] [Abstract][Full Text] [Related]
8. Screening novel drug candidates for Alzheimer's disease by an integrated network and transcriptome analysis.
Peng Y; Yuan M; Xin J; Liu X; Wang J
Bioinformatics; 2020 Nov; 36(17):4626-4632. PubMed ID: 32516365
[TBL] [Abstract][Full Text] [Related]
9. Drug repositioning through integration of prior knowledge and projections of drugs and diseases.
Xuan P; Cao Y; Zhang T; Wang X; Pan S; Shen T
Bioinformatics; 2019 Oct; 35(20):4108-4119. PubMed ID: 30865257
[TBL] [Abstract][Full Text] [Related]
10. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
Hameed PN; Verspoor K; Kusljic S; Halgamuge S
BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
[TBL] [Abstract][Full Text] [Related]
11. Integrating LINCS Data to Evaluate Cancer Transcriptome Modifying Potential of Small-molecule Compounds for Drug Repositioning.
Zhao Y; Liu Y; Bai H
Comb Chem High Throughput Screen; 2021; 24(9):1340-1350. PubMed ID: 33109034
[TBL] [Abstract][Full Text] [Related]
12. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
Zhao M; Yang CC
J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
[TBL] [Abstract][Full Text] [Related]
13. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
Kwon OS; Kim W; Cha HJ; Lee H
Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
[TBL] [Abstract][Full Text] [Related]
14. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
15. Influence of batch effect correction methods on drug induced differential gene expression profiles.
Zhou W; Koudijs KKM; Böhringer S
BMC Bioinformatics; 2019 Aug; 20(1):437. PubMed ID: 31438848
[TBL] [Abstract][Full Text] [Related]
16. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
[TBL] [Abstract][Full Text] [Related]
17. Early repositioning through compound set enrichment analysis: a knowledge-recycling strategy.
Temesi G; Bolgár B; Arany A; Szalai C; Antal P; Mátyus P
Future Med Chem; 2014 Apr; 6(5):563-75. PubMed ID: 24649958
[TBL] [Abstract][Full Text] [Related]
18. DeSigN: connecting gene expression with therapeutics for drug repurposing and development.
Lee BK; Tiong KH; Chang JK; Liew CS; Abdul Rahman ZA; Tan AC; Khang TF; Cheong SC
BMC Genomics; 2017 Jan; 18(Suppl 1):934. PubMed ID: 28198666
[TBL] [Abstract][Full Text] [Related]
19. A Review of Drug Repositioning Based Chemical-induced Cell Line Expression Data.
Wang F; Lei X; Wu FX
Curr Med Chem; 2020; 27(32):5340-5350. PubMed ID: 30381060
[TBL] [Abstract][Full Text] [Related]
20. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
Zhao K; So HC
Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
